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Abstract
Background: There is limited information on prevalence of pulmonary tuberculosis (PTB) in patients with type-1-
diabetes. We assessed the prevalence of PTB in patients with type-1-diabetes attending the outpatient-clinic in a
tertiary-care hospital.
Methods: 151 patients with type-1-diabetes were screened for PTB by clinical examination and chest-radiography.
Sputum Acid-Fast Bacilli Test (AFB) and Mycobacterium tuberculosis (M.tb) culture were performed in patients with
clinical and radiological features suggestive of a possibility of PTB and also in those with history of PTB in the past.
Their average glycated haemoglobin (HbA1c) during preceding 2 years was assessed. Sputum culture positive
patients were managed by a pulmonologist.
Results: 5/151 patients had respiratory symptoms and radiographic findings suggestive of PTB. 20/151 patients
were asymptomatic but had history of PTB. Four of the five symptomatic patients and 12 with past PTB were
positive for sputum M.tb by culture, giving a prevalence of 10.6 % sputum culture positive in type-1-diabetes.
Average HbA1c was comparable in patients with and without positive sputum culture. ESR and Mantoux test were
not discriminatory in these groups. Four clinically symptomatic M.tb culture positive and four asymptomatic
patients with sputum culture positive for M.tb on two occasions (6 weeks apart) were put on antitubercular
treatment (ATT). Patients who were culture positive for M.tb only on one occasion were kept on a close follow up.
Conclusions: Patients with type-1-diabetes mellitus in India have high prevalence of PTB. They need to be actively
screened for PTB by sputum M.tb culture in order to initiate early treatment and to prevent transmission in the community.
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Background
Association between diabetes mellitus and tuberculosis is
known since the mid-twentieth century and has been in-
creasingly drawing attention [1-3]. There is 3.5–5.0 fold
higher risk of tuberculosis in diabetes, which is especially
high in type 1 diabetes [4, 5]. These patients have high
relapse after antitubercular drugs and high mortality in case
of delayed diagnosis. The World Health Organization
recommends that patients with diabetes and cough of >
2 weeks need further evaluation for possibility of tubercu-
losis [6].
Recently, Lin et al. screened 3,087 patients with type 2 dia-
betes and detected 11 fresh cases of pulmonary tuberculosis;
indicating relevance of WHO recommendations [7]. There is
paucity of similar information in type 1 diabetes mellitus.
Tuberculosis is common in India with prevalence of 256/
100,000 persons. In such a scenario, likelihood of tuberculosis
might be high in patients with diabetes mellitus. The present
study assessed the prevalence of pulmonary tuberculosis
(PTB) in a cohort of patients with type 1 diabetes attending a
tertiary care hospital in North India and its correlation with
glycemic statusmaintained during the preceding 2 years.
* Correspondence: drurvashi@gmail.com; gosravinder@hotmail.com
2Department of Microbiology, All India Institute of Medical Sciences, New
Delhi 110029, India
1Department of Endocrinology and Metabolism, All India Institute of Medical
Sciences, New Delhi 110029, India
Full list of author information is available at the end of the article
© 2016 Nair et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Nair et al. Multidisciplinary Respiratory Medicine  (2016) 11:22 
DOI 10.1186/s40248-016-0058-z
Methods
Study subjects were insulin-requiring patients with age
of onset of diabetes < 30 years, attending the ‘Diabetes of
young’ clinic at All India Institute of Medical Sciences,
New Delhi. The clinic is operating since 1989–90 on
weekly basis and has a weekly attendance of 30–40 pa-
tients. The study was carried out during December
2014-June 2015. All the new and follow up patients
attending the clinic between 8.30 and 9.30 am were included
so as to complete the study investigations on the same day.
Pregnant and lactating female patients were excluded. Clinical
details including age of onset of diabetes, presence of albumin-
uria, retinopathy and HbA1c values available during the pre-
ceding 2 years were recorded from clinic records. All the
patients were individually assessed for symptoms and signs
suggestive of active PTB such as fever, cough > 2 weeks,
hemoptysis and noticeable weight loss during past sixmonths.
Past history of treatment for tuberculosis was also recorded.
All the patients were recruited after written informed consent.
The study protocol was approved by the Institutional review
board of All India Institute of Medical Sciences, New Delhi.
All procedures followed were in accordance with the ethical
standards of the responsible committee on human experi-
mentation (institutional and national) and with the Helsinki
Declaration of 1975, as revised in 2008.
Digital chest radiograph, complete blood count,
erythrocyte sedimentation rate (ESR), HbA1c and tuber-
culin skin test (TST) was performed for all the patients
on their first visit. TST was performed with 2 tuberculin
units of purified protein derivative (Span diagnostics,
Surat, India) given intradermally on the volar aspect of
the left forearm. The transverse diameter of induration
was measured after 48–72 h using a ball-point pen and a
transparent ruler. Patients were considered to have la-
tent tuberculosis infection when induration was ≥10 mm
with no other features suggestive of active tuberculosis.
The definitions of the PTB were made as per the defin-
ition and reporting framework of WHO criteria [6]. Briefly,
patients with clinical symptoms suggestive of active tuber-
culosis, radiographic findings such as consolidation, fibro-
cavitary disease and hilar lymphadenopathy and those with
history of treatment for tuberculosis in the past were ad-
vised to bring a morning sputum specimen for AFB smear,
M.tb culture and antitubercular drug susceptibility testing
(DST). A second sputum sample was collected in the
clinic. Patients who were unable to expectorate were given
nebulization with 3 % saline solution for 10 min in an iso-
lated area to induce sputum. Clinically asymptomatic pa-
tients with history of treatment for tuberculosis in the past
or features of healed tuberculosis on chest radiography
with sputum M.tb culture positive in any of the two spu-
tum samples were further followed by a pulmonologist.
For these patients, two more sputum cultures for M.tb and
chest radiography were performed after six weeks. The
World Health Organization approved rapid diagnostics,
such as Xpert MTB/RIF, was not used for diagnosis in this
study cohort for logistic reasons [6].
Sputum AFB smear was stained by Ziehl-Neelsen
technique. M.tb culture and DST for rifampicin and iso-
niazid were performed on Middlebrook 7H10 agar [8].
Complete blood count, ESR and chest-radiography were
performed in the general hospital departments of the
hospital. Glutamic acid decarboxylase autoantibodies
(Normal < 1.0 units/ml) were assayed in the hormone
service laboratory of the endocrine Department.
Follow up and treatment for patients with sputum M.tb
culture positive
Symptomatic patients
Patients with clinical symptoms and/or chest radiograph
suggestive of active pulmonary lesion with sputum
smear or culture positive for M.tb were defined as clinic-
ally active PTB cases and were initiated on ATT. Those
with symptoms of chest infection but without sputum
smear or culture positive were given a course of antibi-
otics therapy other than fluoroquinolones. If the symp-
toms persisted after two weeks and repeat sputum
smear or culture yielded a positive result, were also con-
sidered as bacteriologically active PTB cases and were
initiated on ATT.
Clinically asymptomatic patients
Clinically asymptomatic patients who had M.tb culture
positive in at least two sputum samples taken six weeks
apart were advised ATT. Patients who developed symp-
toms or radiographic findings suggestive of tuberculosis
during follow up were also put on ATT irrespective of
repeat sputum M.tb culture. Patients with no clinical
symptoms and normal chest radiograph who had only
one sputum culture positive for M.tb were designated as
subclinical PTB cases and advised regular follow up in
the pulmonology clinic.
Statistical analysis
Data are shown as mean ± SD and frequencies in percent-
age. The clinical and biochemical characteristics of patients
with and without PTB were compared by parametric and
nonparametric tests as appropriate. All statistical analyses
were imputed on SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
A two tailed p of < 0.05 was considered significant.
Results
Figure 1 shows the flow of 152 patients in the study.
One of them did not agree to participate and therefore,
was excluded. Final analysis was carried out in 151 pa-
tients (males 76, females 75). History of spontaneous dia-
betic ketoacidosis during the course of the disease was
present in 105 subjects. GAD65 autoantibodies were tested
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in 136 subjects and were positive in 47.1 %. Their mean
age, duration of diabetes from onset of symptoms and
BMI were 28.2 ± 11.22 years, 13.2 ± 7.54 years and 20.8 ±
3.74 kg/m2 respectively. History of smoking and alcohol
intake was present in one each. Their mean HbA1c at
screening and average of the last four values available dur-
ing follow up in diabetic clinic were 9.0 (75 mmol/mol) ±
1.8 % and 9.0 (75 mmol/mol) ± 2.1 %, respectively. Retin-
opathy, urinary total protein excretion >150 mg/24 h and
chronic kidney disease (estimated glomerular filtration
rate < 60 ml/min) were present in 22 %, 8 % and 8.6 %
respectively. The mean hemoglobin and total leukocyte
count were 12.7 ± 2 gm% and 7435 ± 1877/mm3, respect-
ively. The mean erythrocyte sedimentation rate of the
study group was 18.1 ± 15.77 mm/hour and a total of 60
patients had elevated ESR (≥20 and ≥ 15 mm/hr for
females and males respectively).
Symptoms, chest radiograph and sputum M.tb culture at
presentation
Clinical features suggestive of active PTB were present
in five of the 151 patients screened, though they did not
see the physician for these symptoms. These five in-
cluded two with cough for more than two weeks (one
with fibrocavitary consolidation on chest radiography
and the other with normal radiography); one with sig-
nificant weight loss and left upper zone cavity on chest
radiography; two without symptoms but chest radiog-
raphy suggestive of tuberculosis (one with consolidation
and the other with hilar adenopathy). Twenty patients
had no overt clinical features of PTB but had history of
tuberculosis in the past. The details of all these 25 pa-
tients including their ESR, Mantoux, chest radiography
and status of sputum M.tb culture on initial screening is
given in Table 1.
Fig. 1 Flow of patients in the study
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None of them had sputum smear positive for AFB.
However, 16 of them had sputum M.tb culture positive
in at least one of the two sputum specimens. All M.tb
cultures were sensitive to rifampicin and isoniazid. ESR
was elevated in significantly higher proportion of pa-
tients with positive M.tb culture as compared to those
with negative culture (10/16 vs. 1/9, P = 0.03). TST was
not significantly different in these two groups (5/16 vs.
3/9, p = 0.99). Four out of the five patients with clinical
symptoms or chest radiography suggestive of PTB had
positive M.tb culture. The fifth patient had cough, which
responded to a course of oral antibiotics. Among twenty
asymptomatic patients who had past history of tubercu-
losis, twelve had positive sputum M.tb. culture.
Clinical correlates of sputum M.tb culture positive
patients
Table 2 shows the clinical characteristics of 16 patients
with sputum M.tb culture positive in comparison to
those in whom clinical, radiological and bacteriological
features were not suggestive of PTB (n = 135). Patients
with positive M.tb culture were older on an average by
10 years (36.9 ± 10.5 vs. 27.1 ± 10.87 years, p < 0.001) and
had significantly higher duration of diabetes (18.9 ± 5.38
Table 1 Clinical findings of 25 patients screened for sputum M.tb positivity and their follow up in the pulmonology clinic
S N Age/
Sex
Findings at initial screening Follow up in the Pulmonology clinic
Indication for screening by sputum M.Tb culture Sputum
culture
M.tb
ESRmm/
hr
TSTmm Symptom Radiograph Sputum
culture
M.Tb
ATT
History Radiography Ist 2nd Ist 2nd
1 40,M Wt loss, Past TB Lt upper lobe Cavity +ve +ve 40 11 None No change -ve +ve Yes
2 25,F Cough > 2 weeks &
Past TB
Lt upper lobe fibrocavitory
consolidation
+ve +ve 30 11 Hemoptysis No change -ve +ve Yes
3 36,F Past TB Lt upper lobe Consolidation +ve +ve 37 11 Wt loss No change -ve -ve Yes
4 28,F None Rt hilar adenopathy +ve -ve 8 5 None No change -ve +ve Yes
5 25,F Past TB Normal +ve -ve 38 10 Fever > 2
weeks
Normal -ve +ve Yes
6 22,F Past TB Normal -ve +ve 118 5 Pericardial
effusion
Pericardial
effusion
ND ND Yes
7 28,F Past TB Rt pleural thickening +ve +ve 15 9 None No change -ve +ve Yes
8 47,F Past TB Rt bronchiectasis +ve SNA 26 10 None No change -ve +ve Yes
9 65,F Past TB Lt upper lobe Fibrosis +ve -ve 20 8 None No change -ve -ve No
10 39,M Past TB Normal SNA -ve 10 8 None Expired No
11 37,F Past TB Normal +ve SNA 5 0 None Normal -ve -ve No
12 40,F Past TB Rt lower lobe fibrosis -ve +ve 5 6 None Normal -ve -ve No
13 46,
M
Past TB Normal +ve -ve 30 4 None Normal -ve -ve No
14 36,M Past TB Normal +ve SNA 15 0 None Normal -ve -ve No
15 32,M Past TB Normal +ve +ve 10 2 None Normal -ve -ve No
16 40,M Past TB Normal -ve +ve 10 0 None Normal -ve -ve No
17 22,M Cough > 2 weeks Normal -ve -ve 3 6 None NR NR NR No
18 43,M Past TB Rt upper lobe fibrosis & Lt lower
lobe calcification
-ve -ve 5 10 None NR NR NR No
19 34,F Past TB Normal -ve -ve 16 5 None NR NR NR No
20 23,F Past TB Normal -ve -ve 10 4 None NR NR NR No
21 38,
M
Past TB Normal -ve -ve 8 0 None NR NR NR No
22 20,M Past TB Normal -ve -ve 10 10 None NR NR NR No
23 38,M Past TB Normal -ve -ve 5 12 None NR NR NR No
24 30,F Past TB Normal -ve -ve 48 0 None NR NR NR No
25 28,F Past TB Rt pleural thickening -ve -ve 3 0 None NR NR NR No
M male, F female, Lt left, Rt right, TB tuberculosis, wt weight, SNA sample not available, ND not done, NR not required
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vs. 12.5 ± 7.46 years, p < 0.01). Retinopathy and chronic
kidney disease were present in higher proportion of pa-
tients with positive culture (p < 0.001 for both). The
mean HbA1c at the time of screening was comparable in
two groups (8.1 (65 mol/mol) ± 1.7 vs. 9.1 (76 mmol/
mol) ± 2.1 %, p = 0.10). The total numbers of HbA1c
values available during past 2 years were 54 for the 16
patients with positive culture and 430 in others. The
mean HbA1c of all pooled values were also not signifi-
cantly different in these two groups (8.4 (68 mmol/mol)
± 1.7 % vs. 9.1 (76 mmol/mol ± 1.8 %, p = 0.19). Other
clinical and biochemical parameters were comparable in
both groups (Table 2).
Follow up and treatment of patients for PTB
Table 1 gives the follow up details of all the 16 patients
who had positive sputum M.tb culture. Four of them
with symptoms or chest radiography suggestive of tuber-
culosis at presentation were advised ATT. Other patients
were kept under close clinical monitoring for the occur-
rence of symptoms suggestive of tuberculosis. Repeat
sputum culture was carried out after six week interval.
Two patients including one who developed pericardial
effusion and another who developed prolonged fever
within six weeks were advised ATT. One patient who
also had advanced nephropathy died at his native village
home before completion of six week follow up. Two pa-
tients though asymptomatic, again had positive sputum
M.tb culture at six weeks and were put on ATT. Seven
patients who remained asymptomatic and did not grow
M.tb on repeat sputum cultures were advised to remain
under regular follow up in the pulmonology clinic.
Discussion
In the present study, we actively screened for the presence
of PTB among patients with type 1 diabetes, who were on
routine follow up in the endocrine clinic at a tertiary care
hospital. Besides, all the patients with positive M.tb spu-
tum culture were prospectively followed up by an expert
pulmonologist for assessing the need for instituting ATT.
Despite its clinical relevance, there is paucity of such
information with only one similar study available [9].
The present study revealed a high prevalence (10.6 %)
of sputum M.tb culture positivity in type 1 diabetics.
Most of the patients were clinically asymptomatic (87 %)
and only two had symptoms suggestive of tuberculosis
on direct questioning. In the present study, 60 % of the
patients who had previous history of ATT, were cur-
rently asymptomatic but showed positive M.tb sputum
culture. This indicated a high rate of persistence or
Table 2 Baseline characteristics in patients with and without positive sputum M.tb culture
Parameters Sputum M.Tb status P
Negative Positive
(n = 135) (n = 16)
Male: Female (n) 65:70 10:6 0.59
Age (years) 27.1 ± 10.87 36.9 ± 10.5 <0.001
Body mass index (kg/m2) 20.8 ± 3.78 20.9 ± 3.36 0.89
Duration of diabetes (years) 12.5 ± 7.46 18.9 ± 5.38 <0.01
Retinopathy (n) 22 (16.29 %) 11(68.75 %) <0.001
Proteinuria(urine protein >150 mg/24 h) 18 (13.33 %) 4 (25.0 %) 0.22
Chronic kidney disease (eGFR <60 ml/min)(n) 8 (5.5 %) 5 (31.2 %) <0.001
Current HbA1c (%) 9.1 ± 2.1 8.1 ± 1.7 0.10
Pooled HbA1c during (%) 9.1 ± 1.8 8.4 ± 1.7 0.19
Serum total cholesterol (mg/dL) 165.8 ± 36.68 171.8 ± 32.75 0.53
Serum triglycerides (mg/dL) 98.3 ± 54.58 107.7 ± 47.42 0.51
Serum LDL (mg/dL) 93.2 ± 28.98 97.9 ± 27.32 0.53
Serum HDL (mg/dL) 54.1 ± 19.28 51.3 ± 14.47 0.58
Hemoglobin (g/dl) 12.7 ± 2.04 12.8 ± 1.65 0.90
Total leukocytes count/mm3) 7360 ± 1889 8069 ± 1695 0.15
Polymorphs (%) 59.4 ± 9.75 61.1 ± 9.66 0.52
Lymphocyte (%) 30 ± 8.1 28 ± 9.1 0.20
Erythrocyte sedimentation rate (mm/h) 17.0 ± 13.62 27.1 ± 26.80 <0.001
Elevated ESR (n = 147) 50 (38.2 % 10 (62.5 % 0.06
Mantoux (>10 mm) (n = 145) 13 (10.07 %) 5 (31.25 %) 0.02
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relapse of disease in type 1 diabetes with past history of
tuberculosis. The asymptomatic nature of the disease in
most of the M.tb culture positive patients could be re-
lated to their low bacterial load as indicated by smear
negativity on microscopy. Notwithstanding the low spu-
tum M.tb load, 50 % of the patients with positive M.tb
sputum culture required ATT in view of their symptoms
or persistent culture positivity on follow up. Other pa-
tients with sputum M.tb culture positive but with no
current symptoms were advised close follow up in the
respiratory clinic as cases with ‘subclinical PTB’. ESR
and Mantoux test could not reliably discriminate patients
with and without M.tb culture positive. Interestingly, in
the present study, sputum AFB was negative in all the pa-
tients including those in whom sputum culture was posi-
tive for M.tb. Tostmann et al., [10] showed that patients
with smear-negative, culture-positive TB are responsible
for 13 % of TB transmission in Netherland. Recently,
Assael et al. [11] reported that 80 % Mexican immigrants
to USA had smear negative TB, thereby suggesting a need
to include sputum culture as the screening method for TB
diagnosis. The results of the current study suggest the ad-
vantage of sputum M.tb culture over sputum AFB smear
as screening test for diagnosis of tuberculosis in patients
with type 1 diabetes as well.
In the present study, eight clinically asymptomatic
patients with positive sputum M.tb culture, only on one
occasion were put on follow up as subclinical PTB. In
the absence of clear guidelines regarding management,
pulmonologist deferred ATT therapy. However, two
such patients presented with complications within
6 weeks, one developed pericardial effusion and another
developed prolonged fever and were advised ATT. These
patients were asymptomatic and hence were put on
follow up. If ATT had been initiated, based on the first
culture report, the disease progress could have been
halted. Thus there is a need to carry out further studies
and develop clear management strategy among asymp-
tomatic patients with type 1 diabetes showing lower
micobiological load of M.tb.
Patients with diabetes mellitus are at increased risk for
active tuberculosis. Jeon and Murray performed a meta-
analysis of 13 observational studies and reported that
diabetes mellitus was associated with an increased risk
of TB with relative risk of 3.11 (95 % CI 2.27–4.26) [12].
Such increased risk was postulated to be due to multiple
abnormalities in the innate and adaptive immune system
among diabetic subjects [13]. The higher prevalence of
positive M.tb culture in our study population could also
be due to other reasons. These include a higher back-
ground prevalence of tuberculosis among Asian Indians
possibly related to socioeconomic factors such as over-
crowding and malnutrition. Besides, the lower threshold
for screening by including asymptomatic patients with
past history of tuberculosis and use of sputum M.tb cul-
ture could be other reason for the higher prevalence of
tuberculosis detected in the current study population.
Interestingly, despite higher duration of diabetes and
micro-vascular complications in patients with culture
positive than in those without, current or average of the
HbA1c values during past 2 years were not significantly
different. Webb et al. observed 3.5 % prevalence of
symptomatic PTB in 258 patients with type 1 diabetes in
South Africa, which correlated with duration of diabetes
and poor glycemic control [9]. Leung et al. assessed
4690 elderly diabetic patients and observed a three times
increased hazard of active tuberculosis in subjects with
HbA1c greater than 7 % compared with those with
HbA1c less than 7 % [14]. Though the above studies
suggest that poor glycemic control seems to be a risk
factor for tuberculosis, there is paucity of similar studies
assessing relationship between glycemic status and
prevalence of tuberculosis or sputum M.tb positivity. We
had assessed mean HbA1c of the patients during the
preceding 2 years. However, it would not accurately fac-
tor the extent of their dysglycemnia during their entire
course of diabetes during which M.tb infection might
have occurred. Moreover, a host of other abnormalities
such as altered innate response reflected by reduced
CD14+ subtype of monocytes and toll-like receptors-4
expression in the peripheral leukocytes and cell medi-
ated immunity in diabetes might also affect the strength
of association between HbA1c and presence of sputum
M.tb [13, 15, 16]. In our earlier studies, we observed
variable association between HbA1c and genitourinary
infections in patients with diabetes mellitus [17, 18].
There is paucity of studies assessing relationship of
glycemic control with tuberculosis or sputum M.tb
positivity and this could be a subject for future studies.
Thus, to conclude, there is high prevalence of clinically
overt and subclinical PTB in patients with type 1 diabetes.
Physicians managing these patients need to actively screen
them regularly with sputum culture in order to initiate
early treatment and also to protect the community from
exposure to TB transmission.
Conclusions
There is limited information on prevalence of pulmonary
tuberculosis (PTB) in patients with type-1-diabetes. We
assessed the prevalence of PTB in 151 patients with
type-1-diabetes attending the outpatient-clinic in a
tertiary-care hospital. 10.6 % of them showed sputum
M.tb culture positivity; especially in those with past
history of PTB. Thus there is a high prevalence of PTB
in patients with type1 diabetes in India. They need to be
actively screened for PTB by sputum M.tb culture in
order to initiate early treatment and to prevent transmis-
sion in the community.
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